azacitidine,axicabtagene ciloleucel,tisagenlecleucel
daiichi sankyo,gilead,novartis 
['lysa', 'oracle study', 'lymphoma', 'lymsm', 'cc-486', 'oral aza', 'ptcl']
oracle: cc486 v chemo r/r tfh ptcl - lemmonier
- 86 pts, imbalanced in prior lines rx
- med pfs 2.8mo-5.6mo (ns); med os 10.3-18.4mo (sign)
- cc-486 slightly better tolerated
- no diff response 2nd line
interesting. clearly active but trial prob too small. #ash22 #lymsm 
Associate Professor of Haematology and lymphoma specialist at Oxford Cancer and Haematology centre. Christian, husband and father.